Evidence map›Paper›PMID 32997395›Full record

SynthesisInfluenza and other respiratory viruses2021

Epidemiology and burden of illness of seasonal influenza among the elderly in Japan: A systematic literature review and vaccine effectiveness meta-analysis.

Kiyosu Taniguchi, Shunya Ikeda, Yuriko Hagiwara, Daisuke Tsuzuki, Marwa Klai, Yoko Sakai, Bruce Crawford, Joshua Nealon

Open access · goldAbstract readMeta-AnalysisSystematic Review
In one paragraph

Synthesis in Influenza and other respiratory viruses, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers, 5 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed, 5 pooled it
2.6field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 5 syntheses or guidelines pooled it, 39 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Long-term benefits of nonpharmaceutical interventions for endemic infections are shaped by respiratory pathogen dynamics.Proceedings of the National Academy of Sciences of the United States of America · 2022
    Article
  16. Article
  17. Article
  18. Review
  19. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 6 institutions in 4 countries.

Kiyosu TaniguchiDepartment of Clinical Research, National Mie Hospital, Tsu, Japan.
Shunya IkedaDepartment of Public Health, School of Medicine, International University of Health and Welfare, Narita, Japan.
Yuriko HagiwaraSanofi Pasteur, Tokyo, Japan.ORCID 0000-0002-3754-8278
Daisuke TsuzukiSanofi Pasteur, Tokyo, Japan.
Marwa KlaiSanofi Pasteur, Lyon, France.
Yoko SakaiSyneos Health, Tokyo, Japan.
Bruce CrawfordSyneos Health, Tokyo, Japan.
Joshua NealonSanofi Pasteur, Lyon, France.
Sanofi (France) · FRSyneos Health (United States) · USDepartment of Health · IEInternational University of Health and Welfare · JPNational Mie Hospital · JPSanofi (Japan) · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundElderly populations are particularly vulnerable to influenza and often require extensive clinical support. In Japan, nationwide passive surveillance monitors seasonal influenza but does not capture the full disease burden. We synthesized existing evidence on the epidemiology, vaccine effectiveness (VE), and economic burden of seasonal influenza in the elderly population.

methodsPubMed, EMBASE, and ICHUSHI were searched for articles on seasonal influenza in Japan, published between 1997 and 2018, in English or Japanese. Grey literature was also assessed. A random-effects meta-analysis characterized VE of influenza vaccines among studies reporting this information.

resultsOf 1,147 identified articles, 143 met inclusion criteria. Reported incidence rates varied considerably depending on study design, season, study setting and, most importantly, case definition. In nursing homes, the maximum reported attack rate was 55.2% and in the 16 articles reporting mortality rates, case fatality rates varied from 0.009% to 14.3%. Most hospitalizations were in people aged >60; healthcare costs were partially mitigated by vaccine administration. Meta-analysis estimated overall VE of 19.1% (95% CI: 2.3% - 33.0%) with a high proportion of heterogeneity (I

conclusionsDespite differences between studies that make comparisons challenging, the influenza burden in elderly Japanese is significant. While vaccines are effective, current vaccination programs offer suboptimal protection. Health economic data and cost-effectiveness analyses were limited and represent areas for policy-relevant future research.

Indexed as

Influenza, HumanInfluenza VaccinesAgedCost of IllnessHumansJapanSeasonsVaccinationInfluenza Vaccineseconomic burdenelderlyepidemiologyJapanmeta-analysisseasonal influenzasystematic literature reviewvaccine effectiveness

Identifiers

PMID32997395
PMCPMC7902263
OpenAlexW3091033683

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.